KR20070111533A - 당뇨병 치료용 조성물 및 방법 - Google Patents

당뇨병 치료용 조성물 및 방법 Download PDF

Info

Publication number
KR20070111533A
KR20070111533A KR1020077021372A KR20077021372A KR20070111533A KR 20070111533 A KR20070111533 A KR 20070111533A KR 1020077021372 A KR1020077021372 A KR 1020077021372A KR 20077021372 A KR20077021372 A KR 20077021372A KR 20070111533 A KR20070111533 A KR 20070111533A
Authority
KR
South Korea
Prior art keywords
blood
tvemf
cell
stem cells
cells
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
KR1020077021372A
Other languages
English (en)
Korean (ko)
Inventor
도니 러드
데이비드 울프
Original Assignee
리제네텍 인코포레이티드
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 리제네텍 인코포레이티드 filed Critical 리제네텍 인코포레이티드
Publication of KR20070111533A publication Critical patent/KR20070111533A/ko
Withdrawn legal-status Critical Current

Links

Images

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/14—Blood; Artificial blood
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06—Animal cells or tissues; Human cells or tissues
    • C12N5/0602—Vertebrate cells
    • C12N5/0634—Cells from the blood or the immune system
    • C12N5/0647—Haematopoietic stem cells; Uncommitted or multipotent progenitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/28—Bone marrow; Haematopoietic stem cells; Mesenchymal stem cells of any origin, e.g. adipose-derived stem cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/19—Cytokines; Lymphokines; Interferons
    • A61K38/193—Colony stimulating factors [CSF]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K2035/124—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells the cells being hematopoietic, bone marrow derived or blood cells
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2501/00—Active agents used in cell culture processes, e.g. differentation
    • C12N2501/20—Cytokines; Chemokines
    • C12N2501/22—Colony stimulating factors (G-CSF, GM-CSF)

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Zoology (AREA)
  • General Health & Medical Sciences (AREA)
  • Immunology (AREA)
  • Biomedical Technology (AREA)
  • Hematology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Cell Biology (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Biotechnology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Developmental Biology & Embryology (AREA)
  • Organic Chemistry (AREA)
  • Epidemiology (AREA)
  • Genetics & Genomics (AREA)
  • Wood Science & Technology (AREA)
  • Diabetes (AREA)
  • Virology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Microbiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Obesity (AREA)
  • Endocrinology (AREA)
  • Emergency Medicine (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
KR1020077021372A 2005-02-28 2006-02-27 당뇨병 치료용 조성물 및 방법 Withdrawn KR20070111533A (ko)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US65755305P 2005-02-28 2005-02-28
US60/657,553 2005-02-28

Publications (1)

Publication Number Publication Date
KR20070111533A true KR20070111533A (ko) 2007-11-21

Family

ID=36941684

Family Applications (1)

Application Number Title Priority Date Filing Date
KR1020077021372A Withdrawn KR20070111533A (ko) 2005-02-28 2006-02-27 당뇨병 치료용 조성물 및 방법

Country Status (11)

Country Link
US (1) US20060193838A1 (enExample)
EP (1) EP1855535A4 (enExample)
JP (1) JP2008531695A (enExample)
KR (1) KR20070111533A (enExample)
CN (1) CN101188941A (enExample)
BR (1) BRPI0607882A2 (enExample)
CA (1) CA2599275A1 (enExample)
EA (1) EA200701826A1 (enExample)
IL (1) IL185555A0 (enExample)
MX (1) MX2007010531A (enExample)
WO (1) WO2006093858A2 (enExample)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20060193839A1 (en) * 2005-02-28 2006-08-31 Donnie Rudd Method of providing readily available cellular material derived from peripheral blood, and a composition thereof
CN101415816A (zh) * 2006-02-02 2009-04-22 雷格内泰克公司 表征生物活性化合物的方法
US20090081752A1 (en) * 2007-09-24 2009-03-26 Dennis Robert G Bioreactor, kit and method of using same
US8993231B2 (en) * 2008-03-18 2015-03-31 Marshall University Research Corporation Methods for stem cell production and therapy
JP6691048B2 (ja) 2013-10-24 2020-04-28 オスペダーレ サン ラファエレ エス．アール．エル 方法
US10202598B2 (en) * 2014-05-30 2019-02-12 Todd Frank Ovokaitys Methods and systems for generation, use, and delivery of activated stem cells
US9410143B1 (en) 2014-06-10 2016-08-09 Endonovo Therapeutics, Inc. Biological molecules produced by electromagnetically stimulating living mammalian cells

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5192553A (en) * 1987-11-12 1993-03-09 Biocyte Corporation Isolation and preservation of fetal and neonatal hematopoietic stem and progenitor cells of the blood and methods of therapeutic use
US5728581A (en) * 1995-06-07 1998-03-17 Systemix, Inc. Method of expanding hematopoietic stem cells, reagents and bioreactors for use therein
US6962698B1 (en) * 1998-02-17 2005-11-08 Gamida Cell Ltd. Methods of controlling proliferation and differentiation of stem and progenitor cells
US6485963B1 (en) * 2000-06-02 2002-11-26 The United States Of America As Represented By The Administrator Of The National Aeronautics And Space Administration Growth stimulation of biological cells and tissue by electromagnetic fields and uses thereof
AU2002220712A1 (en) * 2000-11-29 2002-06-11 William Rader Stem cells, method for expansion in vitro and use thereof
AU2003277205A1 (en) * 2002-10-02 2004-04-23 New York University Adult bone marrow derived stem cells
DE10362002B4 (de) * 2003-06-23 2006-10-12 Fraunhofer-Gesellschaft zur Förderung der angewandten Forschung e.V. Adulte pluripotente Stammzellen
US20060205071A1 (en) * 2003-07-17 2006-09-14 Gamida-Cell Ltd. Methods for ex-vivo expanding stem/progenitor cells
US20050084962A1 (en) * 2003-08-20 2005-04-21 Bruce Simon Methods of treatment using electromagnetic field stimulated stem cells
US20080057042A1 (en) * 2005-01-27 2008-03-06 Donnie Rudd Method of providing readily available cellular material derived from cord blood, and a composition thereof
US20080050348A1 (en) * 2006-02-27 2008-02-28 Donnie Rudd Method and composition for repairing heart tissue
US20080075700A1 (en) * 2006-02-27 2008-03-27 Wolf David A Method and composition for treating diabetes

Also Published As

Publication number Publication date
WO2006093858A2 (en) 2006-09-08
JP2008531695A (ja) 2008-08-14
BRPI0607882A2 (pt) 2009-11-24
CN101188941A (zh) 2008-05-28
EP1855535A4 (en) 2009-10-14
WO2006093858A3 (en) 2006-11-30
CA2599275A1 (en) 2006-09-08
US20060193838A1 (en) 2006-08-31
EA200701826A1 (ru) 2008-04-28
EP1855535A2 (en) 2007-11-21
IL185555A0 (en) 2009-02-11
MX2007010531A (es) 2007-11-08

Similar Documents

Publication Publication Date Title
US20070117087A1 (en) Method of providing readily available cellular material derived from peripheral blood, and a compositoin thereof
KR20070103431A (ko) 제대혈로부터 유래한 용이하게 가능한 세포 물질을제공하는 방법 및 그의 조성물
US20080075700A1 (en) Method and composition for treating diabetes
US20080057042A1 (en) Method of providing readily available cellular material derived from cord blood, and a composition thereof
KR20070112205A (ko) 심장 조직 재생용 조성물 및 방법
KR20070111533A (ko) 당뇨병 치료용 조성물 및 방법
US20080075704A1 (en) Method of providing readily available cellular material derived from peripheral blood, and a composition thereof
US20080171020A1 (en) Method and composition for repairing epithelial and other cells and tissue
WO2009025723A1 (en) Method and composition for treating a diabetic condition
CN101160046A (zh) 提供容易获得的源于外周血的细胞材料的方法及其组合物
CA2597963A1 (en) Method of providing readily available cellular material derived from peripheral blood and a composition thereof
WO2007058929A2 (en) Composition for reducing problems associated with sickle cell disease using low temperature storage
CA2597971A1 (en) Method and composition for repairing epithelial and other cells and tissue
CA2597972A1 (en) Method and composition for treating diabetes
CA2595744A1 (en) Method of providing readily available cellular material derived from cord blood, and a composition thereof

Legal Events

Date Code Title Description
PA0105 International application

Patent event date: 20070917

Patent event code: PA01051R01D

Comment text: International Patent Application

PG1501 Laying open of application
PC1203 Withdrawal of no request for examination
WITN Application deemed withdrawn, e.g. because no request for examination was filed or no examination fee was paid